Anteris Technologies Global (NASDAQ:AVR) versus Heart Test Laboratories (NASDAQ:HSCS) Head-To-Head Survey

Anteris Technologies Global (NASDAQ:AVR) and Heart Test Laboratories (NASDAQ:HSCS) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, earnings, profitability, risk and dividends.

Profitability

This table compares Anteris Technologies Global and Heart Test Laboratories’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	N/A	N/A	N/A
Heart Test Laboratories	N/A	-117.76%	-84.09%

Insider & Institutional Ownership

17.2% of Heart Test Laboratories shares are held by institutional investors. 1.8% of Heart Test Laboratories shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Earnings & Valuation

This table compares Anteris Technologies Global and Heart Test Laboratories”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anteris Technologies Global	N/A	N/A	N/A	N/A	N/A
Heart Test Laboratories	$14,700.00	224.00	-$6.61 million	($7.91)	-0.42

Anteris Technologies Global has higher earnings, but lower revenue than Heart Test Laboratories.

Analyst Recommendations

This is a summary of recent ratings and target prices for Anteris Technologies Global and Heart Test Laboratories, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	0	0	4	0	3.00
Heart Test Laboratories	0	0	2	0	3.00

Anteris Technologies Global presently has a consensus price target of $16.50, indicating a potential upside of 130.13%. Heart Test Laboratories has a consensus price target of $13.50, indicating a potential upside of 301.79%. Given Heart Test Laboratories’ higher possible upside, analysts plainly believe Heart Test Laboratories is more favorable than Anteris Technologies Global.

Summary

Heart Test Laboratories beats Anteris Technologies Global on 4 of the 7 factors compared between the two stocks.

About Anteris Technologies Global

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

About Heart Test Laboratories

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.